HomeFLUOROCHEM › Filing
🔔 Get instant alerts when FLUOROCHEM files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 12 Aug 2026, 15:01 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q1FY27 - Chemical segment revenue up 23% YoY to Rs. 1,574 Cr; EBITDA up 29% YoY to Rs. 458 Cr - Consolidated revenue Rs. 1,588 Cr, +24% YoY; EBITDA Rs. 428 Cr, +24% YoY; PAT Rs. 219 Cr, +20% YoY - ROCE improved to 16.63% (+258 bps) and ROE to 15.18% (+301 bps) vs FY26 - Battery materials segment progressing capacity expansion; commercial sales to start soon - Fluoropolymers and fluorochemicals segments show strong growth; R32 capacity expansion underway - Bulk chemicals demand stable; caustic soda outlook steady for FY27 - Total capex Rs. 6,000 Cr by FY28 targeting 25%+ EBITDA margin and 2x asset turnover - ESG scores improved significantly; recognized in sustainability awards
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 FLUOROCHEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add FLUOROCHEM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Gujarat Fluorochemicals Limited

Important. The summary above is generated automatically from Gujarat Fluorochemicals Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.